United Kingdom: Food and Drugs Law

Subscribe
Welcome to the Mondaq Food, Drugs, Healthcare, Life Sciences homepage, here you will find thought leadership articles, podcasts, videos and webinars providing insights covering topics such as Food and Drugs Law, Healthcare, Life Sciences, Biotechnology and Nanotechnology.
Article
When Is A Synbio Company A Gene Therapy Company?
The UK's medicines regulator is proposing fundamental changes to how gene therapy products are defined, shifting from origin-based classifications to mechanism-driven frameworks. This consultation raises critical questions about where regulatory boundaries will be drawn for synthetic biology, genome editing platforms, and engineered cell therapies as biotechnology advances beyond traditional biological manufacturing.
United Kingdom Healthcare
PC
Potter Clarkson
Article
Family Calls For Better Understanding Of Ketamine Addiction To Help Reduce Drug-related Deaths
A mother shares the heartbreaking story of her 22-year-old daughter's death from ketamine addiction, revealing how recreational drug use spiraled into a debilitating condition called ketamine bladder that caused chronic pain and ultimately led to fatal complications. The case exposes critical gaps in healthcare support for ketamine addiction and raises urgent questions about education, treatment pathways, and the accessibility of this Class B substance.
United Kingdom Healthcare
RB
Rothera Bray
Article
EU Agrees To Delay Key AI Act Compliance Deadlines
The European Union has reached a political agreement to significantly extend compliance deadlines for high-risk AI systems under the AI Act, with businesses now having until December 2027 or August 2028 depending on their category. The revised framework introduces separate timelines for different types of high-risk AI applications, narrows certain definitions, and provides regulatory relief for small and medium-sized companies while adding new prohibitions on non-consensual intimate content generation.
United Kingdom Technology
TS
Travers Smith LLP
Article
ASA And CAP Annual Report 2025: Smarter, Proactive Advertising Regulation
The ASA and CAP's Annual Report 2025 reveals a fundamental transformation in UK advertising regulation, with AI-enabled monitoring now scanning nearly 60 million online ads and proactive enforcement overtaking reactive complaints work. From prescription weight-loss medicines to influencer disclosures and green claims, the report exposes critical compliance gaps across multiple sectors while signaling an era of unprecedented data-driven scrutiny.
United Kingdom Media & IT
GA
Global Advertising Lawyers Alliance (GALA)
See more